xiidra 50 MG/ML Ophthalmic Solution
- RxCUI
- 1801840
- RxNorm name
- xiidra 50 MG/ML Ophthalmic Solution
- Display name
- xiidra 50 MG/ML Ophthalmic Solution
- Full name
- xiidra 50 MG/ML Ophthalmic Solution
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:07
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Xiidra | LIFITEGRAST | Novartis Pharmaceuticals Corporation | 8589d376-ac10-4ddb-9c53-2e0c8d5675c4 | 2025-08-18 | Adverse reactions | 1801840 |
| Xiidra | LIFITEGRAST | Bausch & Lomb Incorporated | 1a914080-a3c0-44be-b601-0ae3160e77eb | 2024-11-21 | Adverse reactions | 1801840 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8589d376-ac10-4ddb-9c53-2e0c8d5675c4 | xiidra 5 % Ophthalmic Solution [PSN] · lifitegrast 50 MG/ML Ophthalmic Solution [Xiidra] [SBD] · xiidra 50 MG/ML Ophthalmic Solution [SY] | 3 | 6 | These highlights do not include all the information needed to use XIIDRA safely and effectively. See full prescribing information for XIIDRA. XIIDRA ® (lifitegrast ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2016 | 20250818 |
| 1a914080-a3c0-44be-b601-0ae3160e77eb | xiidra 5 % Ophthalmic Solution [PSN] · lifitegrast 50 MG/ML Ophthalmic Solution [Xiidra] [SBD] · xiidra 50 MG/ML Ophthalmic Solution [SY] | 3 | 5 | These highlights do not include all the information needed to use XIIDRA safely and effectively. See full prescribing information for XIIDRA. XIIDRA ® (lifitegrast ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2016 | 20241121 |